Child & Adolescent Psychopharmacology 2021

March 19, 2021 to March 21, 2021

Complex challenges and evolving guidelines are changing the way you care for young psychiatric patients. These area include new diagnostic criteria, patient-centered care models, new trends in substance abuse, research advances on genetics, and much more. It is more important than ever to find education that not only covers all these topics, but is also innovative, engaging, and empowers you to reach improved outcomes.

That's why it's critical to attend this hands-on, comprehensive conference. It provides psychiatrists, pediatricians, primary care and family practice physicians, nursing professionals, psychologists, social workers, and other mental health professionals with insights to optimize your assessment, treatment, and management of child and adolescent patients with psychiatric conditions.

  • Meet and engage face-to-face with renowned clinician-researchers who share the latest advances in their fields
  • Find guidance for complex signs and symptoms such as emotional outbursts, mood swings, and strange eating habits that can be indicative of psychiatric disorders yet can also be part of normal child development
  • Translate the latest research into optimal assessment and treatment strategies for anxiety, substance abuse, depression, eating disorders, OCD, psychosis, and much more

Conference will be held in Eastern Standard Time (EST).


Note


Our flexible registration fits your schedule. Choose to attend the weekend-long Child & Adolescent Psychopharmacology conference or sign up for just the Sunday ADHD program here: lms.mghcme.org/ADHD2021 
 


 

Pricing

MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before January 29, 2021): $595.00
Early Bird Registration (on or before February 15, 2021): $695.00
Regular Registration (after February 15, 2021): $795.00

Other Professionals or Trainees
Super Early Bird Registration (on or before January 29, 2021): $495.00
Early Bird Registration (on or before February 15, 2021): $595.00
Regular Registration (after February 15, 2021): $695.00

SUNDAY ONLY (ADHD full day course)
MDs/Doctoral-Level Professionals: $345.00
Other Professionals or Trainees: $275.00

If you are interested in attending the Sunday ADHD sessions ONLY, you can register for them by clicking here. This is a full day program that concludes the Child & Adolescent Psychopharmacology conference and offers 8 CME/CEU credits.

Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by February 26, 2021.  No refunds will be issued for refund requests made after February 26, 2021. Payments made may not be applied to future conferences or other educational activities.  There are no exceptions to these policies.

***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.

Syllabus
 

E-SYLLABUS (FRIDAY-SUNDAY)
We provide all attendees registered for the 3 day conference with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference. 

SUNDAY ADHD E-SYLLABUS
If you register for the Sunday ADHD only option, you will have access to the Sunday ADHD conference materials via e-syllabus. This will be emailed to you in advance of the conference. You will not have Friday-Sunday e-syllabus access. The e-syllabus will be available for 30 days after the conference. 

Target Audience

  • Psychiatrists
  • Primary care and family practice physicians
  • Pediatricians
  • Psychologists
  • Nursing professionals
  • Social workers
  • Residents
  • Other mental health, primary care and pediatric clinicians

Learning Objectives

  • Recognize the presentation, diagnosis, and current treatment options available for attention deficit and hyperactivity in childhood and adolescence.
  • Identify the presentation, diagnosis, and current treatment options available for behavioral problems and pervasive developmental disorders.
  • Discuss the presentation, diagnosis, and current treatment options available for depression, psychosis, manic depression, and anxiety.
  • Compare and contrast basic neuropharmacology, neuropsychologic testing data, psychopharmacologic properties of compounds, and the implications of psychiatric genetics for guiding day-to-day pediatric psychopharmacology treatment.
  • Recognize the risk management issues associated with adolescent substance use disorder and smoking, ethical and safe use of psychotropics, suicide risk and prevention, cardiovascular side effects and medical liability of stimulants, and liability prevention in psychopharmacology.
  • Review the comorbidity of ADHD with post-traumatic stress disorder and traumatic brain injury.
  • Explore emotional dysregulation, executive function and learning disorders in the context of ADHD.
  • Describe the relationship between antidepressants and suicide risk.
  • Discuss the available naturopathic treatments for emotional dysregulation in youth, including pros, cons, and available evidence.
  • Examine the evidence base for the Pediatric Autoimmune Neurological Disorder Associated with Streptococcus symptoms and its relation to OCD.
  • Describe the presentation, diagnosis, and current treatment options available for childhood onset schizophrenia.
  • Compare and contrast psychotherapeutic treatment approaches for children including DBT, CBT, and others.
  • Explore how animal models provide insight into child and adolescent psychiatric conditions, using ADHD as a model system.
  • Compare and contrast emotional dysregulation from mania, including presentation, course, and treatment.
  • Examine the relationship between learning disorders and ADHD.
  • Describe adult ADHD and discuss the controversies surrounding its diagnosis and treatment.
  • Examine the legal issues involved in treating individuals with ADHD and related disorders.
  • Describe the problems associated with treatment non-adherence and provide strategies to improve adherence in the clinical setting.
Course summary
Available credit: 
  • 24.00 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.

    McLean Hospital designates this Live activity for a maximum of 24.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

  • 24.00 Nursing Contact Hours

    Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.

    This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 24.00 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.

  • 24.00 Social Workers

    The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers

    This program has been approved for 24.00 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D90154

  • 24.00 Participation

    This course allows other providers to claim a Participation Certificate upon successful completion of this course.

    Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.

  • 24.00 Psychologists CE Credit

    The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.

    This offering meets the criteria for 24.00 Continuing Education (CE) credits per presentation for psychologists.

Course opens: 
11/02/2020
Course expires: 
10/31/2021
Event starts: 
03/19/2021 - 8:00am
Event ends: 
03/21/2021 - 6:10pm
Cost:
$795.00
Rating: 
3

Child & Adolescent Psychopharmacology Live-Stream

Friday – Sunday, March 19-21, 2021

Conference will be held in Eastern Standard Time (EST)

 

FRIDAY, MARCH 19, 2021

8:00 AM – 8:10 AM                       Welcoming Remarks & Introduction

Joseph Biederman, MD

Overview of Pediatric Psychopharmacology

8:10 AM – 8:30 AM                       Diagnosis & Assessment in Pediatric Psychopharmacology

                                                          Joseph Biederman, MD             

8:30 AM – 8:50 AM                       Implications of Psychiatric Genetics for Psychopharmacology

Stephen V. Faraone, PhD

ADHD­­­

8:50 AM – 9:10 AM                       ADHD Across the Life Cycle

Joseph Biederman, MD

9:10 AM – 9:30 AM                       Pharmacologic Treatment of ADHD Across the Life Cycle: Stimulants

Thomas J. Spencer, MD

9:30 AM – 9:50 AM                       Pharmacologic Treatment of ADHD Across the Life Cycle: Non-

Stimulants

Timothy E. Wilens, MD

9:50 AM – 10:30 AM                     Question & Answer Panel

Moderator: Joseph Biederman, MD

Panelists: Thomas J. Spencer, MD & Timothy E. Wilens, MD, Stephen V. Faraone, PhD

10:30 AM – 10:50 AM                   Break

Substance Use Disorders

10:50 AM – 11:10 AM                   SUD I

Timothy E. Wilens, MD

11:10 AM – 11:30 AM                   SUD II

Amy M. Yule, MD

11:30 AM – 12:10 PM                   Question & Answer Panel

Moderator: Joseph Biederman, MD

Panelists: Amy M. Yule, MD, Timothy E. Wilens, MD

12:10 PM – 1:10 PM                     Lunch Break

Juvenile Depression, Antidepressants and Suicide Risk & PTSD

1:10 PM – 1:30 PM                        Juvenile Depression

Karen Wagner, MD, PhD

1:30 PM – 1:50 PM                        Antidepressants and Suicide Risk and Prevention

David H. Rubin, MD

1:50 PM – 2:10 PM                        ADHD and PTSD

Andrea Spencer, MD

2:10 PM – 2:50 PM                        Question & Answer Panel

Moderator: Joseph Biederman, MD

Panelists: David H. Rubin, MD, Karen Wagner, MD, PhD, Andrea Spencer, MD

2:50 PM – 3:10 PM                        Break

3:10 PM – 4:00 PM                        Ask the Experts

Joseph Biederman, Timothy E. Wilens, MD, Thomas J. Spencer, MD, Janet R. Wozniak, MD

4:00 PM – 5:00 PM                      Pre-Recorded Afternoon Seminar
Previous concurrent sessions will be available on demand after the broadcast.

  1. When your Patient is a Parent with Cancer: Guiding Parents in the Support of Child Resilience

Paula K. Rauch, MD

  1. Educational Connection

Ronna Fried, EdD

  1. Child Resiliency

Aude Henin, PhD

  1. Internet-based Cognitive Behavioral Therapy

Susan Sprich, PhD

       5. Suicide Prevention

Richard Liu, PhD; Jordan Smoller, MD  

SATURDAY, MARCH 20, 2021

8:00 AM – 8:10 AM                       Welcoming Remarks & Introduction
                                                         
David H. Rubin, MD

                                                           OCD, Tourettes & ASD

8:10 AM – 8:30 AM                         Obsessive Compulsive Disorder/PANDAS

Erica Greenberg, MD

8:30 AM – 8:50 AM                         Tourette's Disorder & Tics

Barbara J. Coffey, MD, MS

8:50 AM – 9:10 AM                         Autism Spectrum Disorder

Gagan Joshi, MD

9:10 AM – 9:50 AM                         Question & Answer Panel

Moderator: David H. Rubin, MD

Panelists: Erica Greenberg, MD, Gagan Joshi, MD & Barbara J. Coffey, MD, MS

9:50 AM – 10:10 AM                       Break

Schizophrenia and Pediatric Mania

10:10 AM – 10:30 AM                     Schizophrenia

John W. Tyson, MD

10:30 AM – 10:50 AM                     Juvenile Mania

                                                            Janet R. Wozniak, MD

10:50 AM – 11:10 AM                     Treatment of Mania

Janet R. Wozniak, MD

11:10 AM – 11:50 AM                     Question & Answer Panel

Moderator: David Rubin, MD

Panelists: John W. Tyson, MD & Janet R. Wozniak, MD

11:50 PM – 12:50 PM                     Lunch Break

Psychological Intervention

12:50 PM – 1:10 PM                       Applied Behavioral Analysis

Nathan Call, PhD

1:10 PM – 1:30 PM                          Cognitive Behavioral Treatment for Young Adults

Aude Henin, PhD

1:30 PM – 1:50 PM                          Dialectic Behavioral Therapy

                                                          Susan Sprich, PhD

1:50 PM – 2:10 PM                          Cognitive Behavioral Therapy for Anxiety in Young Children

                                                            Aude Henin, PhD

2:10 PM – 2:50 PM                         Question & Answer Panel

Moderator: Joseph Biederman, MD

Panelists: Aude Henin, PhD, Nathan Call, PhD, Susan Sprich, PhD

Anxiety Disorders, Eating & Neuropsychology

2:50 PM – 3:10 PM                        Pediatric Anxiety Disorders

Erica L. Greenberg, MD

  3:10 PM – 3:30 PM                      Break

3:30 PM – 3:50 PM                        Eating Disorders

Kamryn T. Eddy, PhD

3:50 PM – 4:10 PM                        Neuropsychology

Ronna Fried, EdD

4:10 PM – 4:30 PM                        Legal Issues in Treating Individuals with ADHD and Related
Disorders

                                                          Ronald Schouten, MD, JD

4:30 PM – 5:10 PM                        Question & Answer Panel

Moderator: David Rubin, MD

Panelists: Erica L. Greenberg, MD & Kamryn T. Eddy, PhD, Ronna Fried, EdD, Ronald Schouten, MD, JD

5:10 PM – 5:50 PM                        “Ask the Experts”

Joseph Biederman, MD, Janet R. Wozniak, MD, Timothy E. Wilens, MD, Thomas J. Spencer, MD

5:50 PM                                           Adjourn

SUNDAY, MARCH 21, 2020

8:00 AM – 8:10 AM                         Welcoming Remarks & Introduction

Joseph Biederman, MD

Diagnosis and Underpinnings of ADHD

8:10 AM – 8:30 AM                         Definitions and Overview of ADHD

Joseph Biederman, MD

8:30 AM – 8:50 AM                         Animal Models and Novel Insights into the Neurobiology of ADHD

Pradeep G. Bhide, PhD

8:50 AM – 9:10 AM                         Genetics of ADHD

Stephen V. Faraone, PhD

 9:10 AM – 9:30 AM                        Neuroimaging and ADHD

John Gabrieli, PhD

9:30 AM – 10:10 AM                     Question & Answer Panel

Moderator: Joseph Biederman, MD

Panelists: Stephen V. Faraone, PhD, Pradeep G. Bhide, PhD, John Gabrieli, PhD

10:10 AM – 10:30 AM                   Break

Treatment of ADHD

10:30 AM – 10:50 AM                   Treatment of Pediatric ADHD with Stimulants

Thomas J. Spencer, MD

10:50 AM – 11:10 AM                   Treatment of Pediatric ADHD with Non-Stimulants

Timothy E. Wilens, MD

11:10 AM – 11:30 AM                   Managing Complex ADHD

Timothy E. Wilens, MD

11:30 AM – 11:50 AM                 CBT & Psychosocial Treatments in ADHD

Aude Henin, PhD

11:50 AM – 12:30 PM                 Question & Answer Panel

Moderator: Joseph Biederman, MD

Panelists: Timothy E. Wilens, MD & Aude Henin, PhD

12:30 PM – 1:30 PM                    Lunch Break

Emotional Dysregulation, Executive Function and Learning Disorders

1:30 PM – 1:50 PM                      Distinguishing Emotional Dysregulation from Mania

                                                          Joseph Biederman, MD

1:50 PM – 2:10 PM                      ADHD & Learning Disabilities

Ellen B. Braaten, PhD

2:10 PM – 2:30 PM                      Impact of Pharmacotherapy on Functional Outcomes

Ronna Fried, EdD

2:30 PM – 3:10 PM                      Question & Answer Panel

Moderator: Joseph Biederman, MD

Panelists: Ellen B. Braaten, PhD & Ronna Fried, EdD

3:10 PM – 3:20 PM                      Break

Addressing Comorbidities of ADHD

3:20 PM – 3:40 PM                      ADHD, Tics and Tourette's Disorder

Barbara J. Coffey, MD, MS

3:40 PM – 4:00 PM                      Comorbidity of ADHD with Substance Use Disorders and Associated

Risk Management Issues

Timothy E. Wilens, MD

4:00 PM – 4:20 PM                      Management of ADHD in the Context of Autism Spectrum Disorders

T. Atilla Ceranoglu, MD

4:20 PM – 4:40 PM                      The Serious Problem of Non-Adherence to Treatment

                                                        Joseph Biederman, MD

4:40 PM – 5:00 PM                      Adult Onset of ADHD: Myth or Reality

Joseph Biederman, MD

5:00 PM – 5:40 PM                      Question & Answer Panel

Moderator: Joseph Biederman, MD

Panelists: Timothy E. Wilens, MD, T. Atilla Ceranoglu, MD, Barbara J. Coffey, MD, MS

    5:40 PM – 6:20 PM                      “Ask the Experts”

Joseph Biederman, MD, Janet R. Wozniak, MD, Timothy E. Wilens, MD, Thomas J. Spencer, MD

    6:20 PM                                         Adjourn

 

Course Director(s)

Joseph Biederman, MD

has no relevant financial relationships to disclose at this time.

Thomas Spencer, MD

has no relevant financial relationships to disclose at this time.

Timothy Wilens, MD

has no relevant financial relationships to disclose at this time.
Planner(s)

Joseph Biederman, MD

has no relevant financial relationships to disclose at this time.

David Rubin, MD

has no relevant financial relationships to disclose at this time.
Speaker(s)

Pradeep Bhide, PhD

has no relevant financial relationships to disclose at this time.

Joseph Biederman, MD

has no relevant financial relationships to disclose at this time.

Ellen,Ph.D. Braaten, PhD

has no relevant financial relationships to disclose at this time.

Atilla Ceranoglu, MD

has no relevant financial relationships to disclose at this time.

Barbara Coffey, MD, MS

has no relevant financial relationships to disclose at this time.

Stephen Faraone, PhD

has no relevant financial relationships to disclose at this time.

Ronna Fried, EdD

has no relevant financial relationships to disclose at this time.

John Gabrieli, PhD

has no relevant financial relationships to disclose at this time.

Erica Greenberg, MD

has no relevant financial relationships to disclose at this time.

Nathan Hall, PhD

has no relevant financial relationships to disclose at this time.

Gagan Joshi, MD

has a financial relationship (Other) with Research Support F. Hoffmann-La Roche Ltd.;.

Richard Liu, MD

has no relevant financial relationships to disclose at this time.

Paula Rauch, MD

has no relevant financial relationships to disclose at this time.

David Rubin, MD

has no relevant financial relationships to disclose at this time.

Ronald Schouten, MD

has no relevant financial relationships to disclose at this time.

Jordan Smoller, PhD

has no relevant financial relationships to disclose at this time.

Andrea Spencer, MD

has no relevant financial relationships to disclose at this time.

Thomas Spencer, MD

has no relevant financial relationships to disclose at this time.

John Tyson, MD

has no relevant financial relationships to disclose at this time.

Karen Wagner, MD, PhD

has no relevant financial relationships to disclose at this time.

Timothy Wilens, MD

has no relevant financial relationships to disclose at this time.

Janet,M.D. Wozniak, MD

has no relevant financial relationships to disclose at this time.

Amy Yule, MD

has no relevant financial relationships to disclose at this time.

McLean Hospital designates this educational activity for a maximum of 24 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

  • Full three-day conference registration: 24 AMA PRA Category 1 Credit(s)™
  • Sunday only registration: 8 AMA PRA Category 1 Credit(s)™

Available Credit

  • 24.00 AMA PRA Category 1 Credit™

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.

    McLean Hospital designates this Live activity for a maximum of 24.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

  • 24.00 Nursing Contact Hours

    Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.

    This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 24.00 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.

  • 24.00 Social Workers

    The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers

    This program has been approved for 24.00 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D90154

  • 24.00 Participation

    This course allows other providers to claim a Participation Certificate upon successful completion of this course.

    Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.

  • 24.00 Psychologists CE Credit

    The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.

    This offering meets the criteria for 24.00 Continuing Education (CE) credits per presentation for psychologists.

Price

Cost:
$795.00
Please login or register to take this course.


Registration for this conference is now closed.

For customer service please contact Lynda Reid at mghcme@mgh.harvard.edu or call us at (866) 644-7792 and leave a voicemail.


If you are interested in attending the Sunday ADHD sessions ONLY, you can register for them by clicking here. This is a full day program that concludes the Child & Adolescent Psychopharmacology conference and offers 8 CME/CEU credits.


Planners

Joseph Biederman, MD
Thomas J. Spencer, MD
Timothy E. Wilens, MD
Jane Pimental, MPH
David H. Rubin, MD, reviewer
Susan E. Sprich, PhD psychologist reviwer

Policy on Faculty and Provider Disclosure

It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.

Resolution of Conflict of Interest (COI)

McLean Hospital has implemented a process to resolve COI for each CME activity. In order to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public, McLean Hospital has resolved the conflict by External Content Review.